Mustang Bio Inc.

NASDAQ: MBIO · Real-Time Price · USD
1.74
-0.04 (-2.25%)
At close: Aug 15, 2025, 3:59 PM
1.69
-2.88%
After-hours: Aug 15, 2025, 07:52 PM EDT

Mustang Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.99M 1.99M 1.99M 2.88M 2.88M 2.88M 2.88M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.14M 1.44M 2.09M 1.46M 2.71M 3.11M 3.27M 3.74M 2.39M 2.39M 2.21M 2.07M 2.7M 2.54M 2.36M 1.66M 1.03M 490K
Gross Profit
855K 555K -100K 1.42M 172K -226K -388K -3.74M -2.39M -2.39M -2.21M -2.07M -2.7M -2.54M -2.36M -1.66M -1.03M -490K
Operating Income
-3.61M -11.27M -16.25M -25.43M -35.64M -40.99M -52.08M -61.3M -68.49M -72.84M -76.16M -76.85M -75.08M -71.27M -66.72M -67.34M -60.69M -60.37M
Interest Income
337K 243K 184K 241K 308K 438K 850K 1.05M 1.15M 1.07M 689K 440K 299K 307K 368K 435K 522K 579K
Pretax Income
-3.28M -10.71M -15.75M -23.42M -32.06M -40.1M -51.6M -62.62M -71.56M -74.42M -77.53M -77.94M -75.95M -71.21M -66.37M -66.93M -62.88M -63.12M
Net Income
-3.28M -10.71M -15.75M -23.42M -32.06M -40.1M -53.15M -65.39M -74.32M -77.19M -78.9M -78.1M -76.11M -71.36M -66.37M -66.93M -62.88M -63.12M
Selling & General & Admin
3.18M 3.92M 4.13M 6.46M 7.19M 8.71M 9.61M 9.9M 11.16M 11.18M 12.21M 12.46M 11.44M 10.9M 11.02M 10.78M 10.56M 11.02M
Research & Development
1.78M 6.04M 8.6M 14.33M 23.75M 30.23M 40.71M 51.35M 57.33M 61.66M 63.95M 64.39M 63.64M 60.38M 55.71M 56.57M 50.13M 49.35M
Other Expenses
-1.52M -1.82M -265K -711K -1.04M -314K -254K -889K 112K -317K 34K 6.51M 6.47M 7.47M 7.47M 1.63M 1M n/a
Operating Expenses
3.44M 8.15M 12.47M 20.08M 29.89M 38.2M 49.63M 59.93M 66.84M 71.19M 74.86M 76.18M 75.08M 71.27M 66.72M 67.34M 60.69M 60.37M
Interest Expense
2K 4K 5K 4K 7K 2.94M 4.11M 5.27M 6.3M 4.3M 3.36M 2.2M 1.17M 241K 15K 22K 2.71M 3.32M
Selling & Marketing Expenses
n/a n/a n/a -79K -79K -79K -79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.48M 9.48M 14.46M 21.43M 31.64M 39.64M 50.38M 60.32M 66.84M 71.19M 74.86M 76.18M 75.08M 71.27M 66.72M 67.34M 60.69M 60.37M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 1.55M 2.77M 2.77M 2.84M 1.45M 238K 313K 321K 164K 301K 226K 283K
Shares Outstanding (Basic)
40.21M 5.72M 8.69M 8.69M 8.69M 11.25M 9.22M 8.17M 8.13M 8.09M 7.16M 7.85M 7.65M 6.53M 5.86M 6.08M 5.84M 5.36M
Shares Outstanding (Diluted)
40.21M 5.72M 8.69M 8.69M 8.69M 11.25M 9.22M 8.17M 8.13M 8.09M 7.16M 7.85M 7.65M 6.53M 5.86M 6.08M 5.84M 5.36M
EPS (Basic)
-1.35 -2.1 -2.51 -2.49 -3.56 -4.62 -6.41 -8.39 -9.58 -10.08 -10.89 -11.4 -11.78 -11.74 -11.47 -13.93 -14.52 -16.92
EPS (Diluted)
-1.35 -2.1 -2.51 -2.49 -3.56 -4.62 -6.41 -8.39 -9.58 -10.08 -10.89 -11.4 -11.78 -11.74 -11.47 -13.93 -14.52 -16.92
EBITDA
-3.6M -10.61M -14.85M -22M -30.32M -37.82M -47.98M -57.37M -64.84M -66.91M -71.14M -72.85M -72.07M -68.43M -64M -64.77M -58.24M -57.97M
EBIT
-3.29M -10.72M -15.76M -23.41M -32.06M -39.96M -50.28M -60.14M -68.05M -70.12M -74.17M -75.74M -74.78M -70.97M -66.36M -66.91M -60.17M -59.79M
Depreciation & Amortization
167K 467K 1.12M 1.41M 1.74M 2.14M 2.3M 2.77M 3.21M 3.21M 3.03M 2.89M 2.7M 2.54M 2.36M 2.15M 1.96M 1.87M